University of Manchester and EU Funding Health & Social Care

Size: px

Start display at page:

Download "University of Manchester and EU Funding Health & Social Care"

Candice Skinner
6 years ago
Views:

1 University of Manchester and EU Funding Health & Social Care 1. FP7 Overview Facts and Figures 2. Horizon 2020 Story So Far 3. Future Activities Horizon 2020 and Beyond Claire Faichnie and Liz Fay EU Funding and Development

2 Overview of FP7 Funded Research at Manchester 385 projects Health Health 60 ERC Marie Curie Infrastructures NMP KBBE ICT Energy & Environment Humanities Other

FP7 Project Highlights in Health Theme EURO-URHIS2 European Urban

countries REQUITE - Validating predictive models of radiotherapy

survivors Led by Manchester: 13 partners in 7 countries NOFUN: Novel

3 FP7 Project Highlights in Health Theme EURO-URHIS2 European Urban Health Indicators System Led by Manchester: 16 partners in 13 countries REQUITE - Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors Led by Manchester: 13 partners in 7 countries NOFUN: Novel antifungals to treat resistant organisms Led by Manchester: 5 partners across 4 countries

FP7 Project Highlights Health Focus in Other Themes IFAAM Integrated Approaches to Food Allergen & Allergy

Fisheries, and Biotechnology PRoFouND: Prevention of Falls Network for Dissemination Led by Manchester: 21

(ICT-PSP) FARSEEING: Fall Repository for the design of Smart and Self-Adaptive Environments prolonging

4 FP7 Project Highlights Health Focus in Other Themes IFAAM Integrated Approaches to Food Allergen & Allergy Risk Management Led by Manchester: 39 partners in 18 countries FP7 Theme - Food, Agriculture and Fisheries, and Biotechnology PRoFouND: Prevention of Falls Network for Dissemination Led by Manchester: 21 partners in 12 countries FP7 Area - Information and Communication Technologies Policy Support Programme (ICT-PSP) FARSEEING: Fall Repository for the design of Smart and Self-Adaptive Environments prolonging Independent Living Manchester as partner: 11 partners in 7 countries FP7 Area - Information and Communication Technologies

polarity and tropism in fungi Led by Manchester: 11 partners across 7 countries TRANSACT ITN Transforming

5 FP7 Project Highlights Marie Curie ITNs with Health Focus EpiHealthNet ITN Manchester partner: 9 full partners across 5 countries and 3 associated partners FUNGIBRAIN ITN Sensing and integration of signals governing cell polarity and tropism in fungi Led by Manchester: 11 partners across 7 countries TRANSACT ITN Transforming Transforming Magnetic Resonance Spectroscopy into a Clinical Tool Manchester partner: 10 partners across 8 countries

6 FP7 Project Partners Partners by Country UK UK France Germany Netherlands Italy Spain Switzerland Belgium Austria Sweden Denmark Finland Norway Hungary Poland

7 FP7 Project Partners by Type Main partnerships are with UK or European based Higher Education Institutes. In health area significant involvement of local hospital trusts particularly Central and South Manchester. European Based Research Institutes Max Plank in Germany, Centre for National Scientific Research in France. Charities/Stakeholders Cancer Research, Food Standards, Asthma UK. Local Council involvement limited to Manchester, Oldham and Nottingham.

8 Horizon 2020 Overview Global Level In the first nine months (up to September 2014) more than 30,000 proposals were submitted. 2.1 million visits were registered on the web-based Participants Portal in December 2013 alone with a steady increase since. Nearly 5,300 expert evaluators contracted. Expected success rate lower than FP7 of around 14%. The oversubscription rate was eight times the available budget (compared to on average 5.5 times under FP7). For the European Research Council (ERC) calls there has been a flattening off in proposal numbers, suggesting that the extended demand management measures (restriction of resubmission) have been effective. The impact on oversubscription will be further analysed to show whether certain aspects of the challenge-based approach should be adapted, for example by further clarifying impact statements of call topics.

9 Horizon 2020 Overview Global Level Feedback - Evaluation Summary Reports (ESR) have varied in terms of the detail and level of feedback provided to applicants. Recommendations for involve the development of a set of minimum standards on ESR feedback. Strong participation from industry, including SMEs. SME participation in the Industrial Leadership pillar and the Societal Challenges is estimated to be 24% in terms of applicants and 21% in terms of requested EU funding. In FP7 grant agreements 22% of participants were SMEs receiving overall 19% of EU funding. The new SME Instrument has attracted many small companies new to FP funding (around 70%). The majority of proposals to the SME instrument did not meet the expected standard (88% of proposals were below the threshold of 13 points overall).

10 Horizon 2020 Proposals at Manchester 267 proposals Health ERC MSCA ERC Health 57 Low Carbon MSCA 84 Other societal challenges Science with and for Society FET Industrial Leadership Infrastructures Other

11 Horizon 2020 Health Proposals Understanding health, ageing and disease to second stage, coordinating outline bids, coordinating 2 Effective health promotion, disease prevention, preparedness and screening to second stage, coordinating outline bids, coordinating 1 Improving diagnosis Innovative treatments and technologies Advancing active and healthy ageing Integrated, sustainable, citizen-centred care Improving health information, data exploitation and providing an evidence base for health policies and regulation 2014 & bids submitted 2014 & bids submitted, coordinating & bids submitted 2014 & bids submitted 2014 & bids submitted, coordinating 1

12 Future Activities in Health Area Horizon Suggested priority areas for 2016/17 Health Work Programme Ageing at large Understanding ageing and quantitative evaluation; Conditions, diseases and co-morbidities in the oldest old; Technological innovation; Research on health, social and environmental systems. Personalized medicine, mechanisms, system medicine, biomarkers and diagnostics Chronic multifactorial diseases affecting large sections of the population and Rare Diseases. ICT for health Integration of ICT for health solutions Population health and health promotion Focus on non-communicable diseases Infectious diseases Vaccines; Therapeutics including anti-infectives; Diagnostics and host microbial interactions. Early development Sustainable health and care systems Policy research; implementation research; research on data management and technological change. Environment and health challenge Interactions between the environment and human health and wellbeing; Big data; sustainable health care systems.

Future Activities Beyond Health Societal Challenge http://www.

eu/ Third Health Programme 2014 2020 http://ec.europa.

13 Future Activities Beyond Health Societal Challenge Third Health Programme es/3hp/calls/hp-pj-2014.html

14 Next Steps Working with the University University of Manchester Faculty of Humanities Faculty of Engineering and Physical Sciences Faculty of Medical and Human Sciences Faculty of Life Sciences Institutes Brain, Behaviour & Mental Health Cancer Sciences Cardiovascular Sciences Human Development Inflammation and Repair Population Health Schools Dentistry Nursing, Midwifery and Social Work Psychological Sciences Pharmacy Manchester Medical School ERC; MSCA; Low Carbon; Food Security: Health; Nanotechnologies

15 Further Information Participant portal Register as an Expert - Experts specialising in innovation and business planning urgently needed. University of Manchester Claire Faichnie claire.faichnie@manchester.ac.uk Liz Fay liz.fay@manchester.ac.uk Partner Searches Fit for Health: Healthcompetence: National Contact Points:

Introduction to Horizon 2020

Introduction to Horizon 2020 20.05.2015 Michaela Pöter Management Jülich Content 1. Horizon 2020: Structure and Key Objectives 2. Priority I: Excellent Science 3. Priority II: Industrial Leadership 4.